Olink’s Proximity Extension Assay (PEA) technology is a highly specific and sensitive method for multiplex protein quantification. The technology uses pairs of antibodies, each conjugated to a unique DNA oligonucleotide, that bind to the same target protein. When both antibodies bind their target, their DNA tags come into close proximity, allowing them to hybridize and be extended into a unique DNA barcode that can be accurately quantified. This dual-recognition principle minimizes background noise and provides exceptional specificity and sensitivity, enabling the detection of low-abundance proteins.
Unlike untargeted proteomics approaches, Olink assays measure a predefined set of biologically relevant protein targets using validated antibody pairs. The technology is compatible with a wide range of biological sample types, including plasma, serum, and other clinically relevant research samples. In addition, highly multiplexed protein profiling can be performed from minimal sample input, typically requiring only a few microliters of sample.
Depending on the platform, protein abundance is measured either by quantitative PCR (qPCR) in Olink® Target assays or by next-generation sequencing (NGS) in Olink® Reveal assays. Built-in incubation, extension, and detection controls support data quality assessment, assay reproducibility, and robust cross-sample comparisons.
Olink Target Platforms (qPCR-based Protein Profiling)
Olink® Target platforms, including Target 48, Target 96, and Flex, combine PEA technology with real-time qPCR for targeted protein quantification.
In this workflow, dual-antibody binding generates a unique DNA barcode specific to each protein target. The barcode is subsequently amplified and quantified by qPCR, with the signal directly reflecting the abundance of the target protein in the sample. Depending on the panel, up to 92 proteins can be measured simultaneously with high precision, broad dynamic range, and minimal sample consumption.
Integrated quality controls throughout the workflow ensure reliable performance and reproducible results across samples and experiments.
Olink Reveal (NGS-based Protein Profiling)
Olink® Reveal utilizes the same PEA chemistry but employs next-generation sequencing (NGS) as the readout, enabling large-scale proteomic profiling of approximately 1,000 proteins from as little as 4 µL of sample.
Following DNA barcode generation, sequencing adapters and sample indices are added through PCR, allowing pooled libraries to be analyzed using standard Illumina sequencing workflows. The number of sequencing reads corresponding to each barcode reflects the abundance of the associated protein in the original sample.
Results are reported as Normalized Protein eXpression (NPX) values on a log2 scale, providing robust and highly reproducible relative protein abundance measurements that enable reliable comparisons across samples and experimental groups. The platform offers broad coverage of proteins involved in immunity, inflammation, cardiometabolic disease, neurology, oncology, and other key biological processes.
As with Olink Target assays, built-in assay controls are included to monitor workflow performance and support high-quality data generation. Full list of Olink Reveal analytes can be found from
FIMM Genomics unit offers NanoString nCounter analysis services to support a wide range of research applications, including gene expression profiling and miRNA analysis. The nCounter system provides a robust, sensitive, and highly multiplexed platform for digital quantification of up to 800 RNA or miRNA, in a single reaction, with no need for amplification steps that could introduce bias. The CodeSet probes are about 100 bases in length. Therefore, the system is very resistant to lower RNA quality and is suited for critical samples such as FFPE samples.
Panels available include: